Mingyi Ju

Shenyang, 110122, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Hypoxia-driven immune resistance to anti-PD-1/PD-L1 therapy: Mechanistic insights and therapeutic opportunities.

Hypoxia-driven immune resistance to anti-PD-1/PD-L1 therapy: Mechanistic insights and therapeutic opportunities.

Journal: Pharmacological research

Published: April 15, 2026

Hydrogen Sulfide Promotes TAM-M1 Polarization through Activating IRE-1α Pathway via GRP78 S-Sulfhydrylation to against Breast Cancer.

Hydrogen Sulfide Promotes TAM-M1 Polarization through Activating IRE-1α Pathway via GRP78 S-Sulfhydrylation to against Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 24, 2024

Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: July 22, 2024

Molecular interplay between EIF4 family and circular RNAs in cancer: Mechanisms and therapeutics.

Molecular interplay between EIF4 family and circular RNAs in cancer: Mechanisms and therapeutics.

Journal: European journal of pharmacology

Published: April 05, 2023

Clinical significance of FBXW7 loss of function in human cancers.

Clinical significance of FBXW7 loss of function in human cancers.

Journal: Molecular cancer

Published: November 22, 2021

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer.

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer.

Journal: Frontiers in immunology

Published: November 02, 2021

A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer.

A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer.

Journal: OncoTargets and therapy

Published: July 13, 2021

Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.

Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.

Journal: BMC cancer

Published: October 29, 2020

Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity.

Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity.

Journal: Frontiers in cell and developmental biology

Published: October 27, 2020

m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma.

m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma.

Journal: Frontiers in oncology

Published: September 01, 2020

Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.

Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.

Journal: Pathology oncology research : POR

Published: August 31, 2020

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer.

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer.

Journal: Pathology oncology research : POR

Published: August 20, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026